Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lucira Health Inc | LHDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.4523 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4523 | 0.4523 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.108 - 4.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.4523 | USD |
Lucira Health Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 18.36M | 40.60M | 17.95M | $ 93.06M | $ -83.47M | -1.86 | -0.22 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -12.23M | 4.00% |
Lucira Health News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LHDX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.1438 | 1.45 | 0.12 | 0.6452731 | 127,234,721 | 0.3085 | 214.53% |
| 3 Months | 0.12 | 1.45 | 0.108 | 0.5931704 | 28,542,515 | 0.3323 | 276.92% |
| 6 Months | 1.24 | 1.45 | 0.108 | 0.5890785 | 11,284,924 | -0.7877 | -63.52% |
| 1 Year | 3.80 | 4.35 | 0.108 | 0.6021206 | 5,350,214 | -3.35 | -88.1% |
| 3 Years | 22.10 | 37.985 | 0.108 | 1.80 | 2,888,718 | -21.65 | -97.95% |
| 5 Years | 22.10 | 37.985 | 0.108 | 1.80 | 2,888,718 | -21.65 | -97.95% |
Lucira Health Description
| Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. It has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fit in the palm of a hand. The company's initial focus is within respiratory diseases, and initially for COVID-19 and influenza Types A and B indications. |